TrialPsychiatry and clinical neurosciences2024

Efficacy and safety of intravenous ketamine treatment in Japanese patients with treatment-resistant depression: A double-blind, randomized, placebo-controlled trial.

Yohei Ohtani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.